CTOs on the Move

Chambliss, Bahner

www.cbslawfirm.com

 
Chambliss, Bahner is one of the leading companies in Business Services industry. Chambliss, Bahner is based in Chattanooga, TN. You can find more information on Chambliss, Bahner at www.cbslawfirm.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Brandman's Paint

Brandman's Paint is a Norwalk, CT-based company in the Business Services sector.

Dakota Micro,

Dakota Micro is a company that specializes in the manufacturing of industrial cameras for surveillance and backup purposes. Their cameras are designed to withstand harsh conditions while delivering clear images of farms, worksites, or anywhere safety a...

Kansas NEA

Kansas National Education Association - Kansas NEA the largest association for education professionals in Kansas. Education Empowered

4L Data Intelligence™

4L Data Intelligence™ is the Integr8 AI™ powered company focused on helping our customers and partners deliver better healthcare, insurance and government services at a lower cost by improving data, provider, payment and decision integrity. We are committed to USING THE POWER OF Integr8 AI™ TECHNOLOGY FOR GOOD by helping healthcare payers, health systems, governments and insurers deliver better services and care and reduce trillions of dollars in out-of-control costs by making actionable data accessible in real-time, automating inefficient processes and preventing fraudulent, wasteful and abusive payments that drive up costs. For more information visit 4LData.com.

Whitehawk Therapeutics

Whitehawk Therapeutics is an ADC-focused oncology company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Building on the momentum of drug conjugate technologies, Whitehawks three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers, including in significant populations like lung and ovarian. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. As a pragmatic, discerning and agile organization, we are unafraid to make boldly pragmatic choices. Were experts in the business of biotech, from therapeutics R&D through commercialization, applying our collective talents to intentional drug development. More information on the Company is available at www.whitehawktx.com.